Incyte Pathologists

Michael W. de Tar, M.D.

Dr. de Tar joined Incyte Diagnostics in 1995 and has extensive experience serving as a laboratory medical director at some of our regional medical centers.  He is currently serving as the Laboratory Medical Director at Kootenai Health in Coeur d'Alene, Idaho. His hospital medical directorship duties include directing the histology laboratory, and coordinating immunohistochemical services while maintaining strong relationships within the hospital.

Dr. de Tar spearheaded the integration of breast cancer testing for Her-2/neu gene status by immunohistochemistry and fluorescence in situ hybridization (FISH). He has also been instrumental in developing our molecular testing protocols for in situ hybridization for HPV (tissue diagnostics), Epstein Barr virus (EBER) and ploidy studies (by FISH) for early recurrent disease in patients being monitored for urothelial carcinoma.
Dr. de Tar has subspecialty expertise in gynecologic pathology, placental pathology, cytopathology and pathology of the of the head and neck. He has an additional interest in hematopathology.
After joining Incyte Diagnostics, Dr. de Tar used his strong interest in placental pathology to develop a placental surveillance program for the regional hospitals. The program helps ensure all placentas from complicated pregnancies receive pathologic review. It has played an important role in risk management for the hospitals and clinicians. Additionally, Dr. de Tar created a database of the pathologic findings of over 5,000 placentas that he has expertly reviewed.
Additional Information

« back